Sandu Pharmaceuticals Limited has intimated the Bombay Stock Exchange of the untimely and sad demise of its Promoter and Managing Director, Shri Umesh Sandu (DIN:01132141), on Friday, 19th June 2026.
The company states that his demise is an irreparable loss and that it immensely benefitted from his vision and active participation in various Committee and Board Meetings. Consequent to his demise, he ceases to be a Member of the Audit Committee and the Stakeholders Relationship Committee.
As per the disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the following details were provided:
- Name of the Director: Shri Umesh Sandu (DIN:01132141)
- Capacity: Managing Director
- Date of demise: 19.06.2026
- Promoter/Promoter group: Promoter
- Number of Shares Held: 13,88,693
The Chairman, all Directors, and employees of the company conveyed deep sympathy, sorrow, and condolences to his family members.
The intimation was digitally signed by Pratik Prathamesh Mhambray, Company Secretary & Compliance Officer (ACS 36512).